Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Surgery for Pulmonary Sclerosing Hemangioma: Lobectomy versus Limited Resection

  • Park, Joon-Seok (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Kwhan-Mien (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Shin, Su-Min (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Shim, Hun-Bo (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Hong-Kwan (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2010.06.30
  • Accepted : 2011.01.17
  • Published : 2011.02.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Pulmonary sclerosing hemangioma is a rare thoracic tumor, and pathophysiology or clinical course of this tumor is not yet fully described. Furthermore, there is no consensus on the standard operative procedure for this tumor. Material and Methods: Medical records of thirty-two patients, who underwent surgical resection of pulmonary sclerosing hemangioma from 1996 to 2007, were retrospectively reviewed. Results: Nineteen patients underwent lobectomy and thirteen patients underwent limited resection. Video-assisted thoracoscopic surgery was performed in 9 patients in the latter group. Lymph node dissection was done in 21 patients, and one patient was found to have lymph node metastasis of the tumor. There was no postoperative complication, no early death and no tumor-related late mortality. The mean follow-up duration was 39.3 months (2 months~129 months), and all patients were free of local recurrence and distant metastasis during this period. There was no significant difference in patient's characteristics between the two groups, except that the mean hospital stay was shorter in limited resection group than in lobectomy group (p=0.0031). Conclusion: Pulmonary sclerosing hemangioma usually requires surgical resection for both diagnosis and treatment. Limited resection can decrease hospital stay with a surgical outcome comparable to lobectomy, and may be preferred to lobectomy if sufficient resection margin can be achieved.

Keywords

References

  1. Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer 1956;9:53-75 https://doi.org/10.1002/1097-0142(195601/02)9:1<53::AID-CNCR2820090104>3.0.CO;2-U
  2. Katzenstein AL, Gmelich JT, Carrington CB. Sclerosing hemangioma of the lung. A clinicopathologic study of 51 cases. Am J Surg Pathol 1980;4:343-56. https://doi.org/10.1097/00000478-198008000-00003
  3. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies. Am J Surg Pathol 2000;24:906-16. https://doi.org/10.1097/00000478-200007000-00002
  4. Sakamoto K, Okita M, Kumagiri H, Kawamura S, Takeuchi K, Mikami R. Sclerosing hemangioma isolated to the mediastinum. Ann Thorac Surg 2003;75:1021-3. https://doi.org/10.1016/S0003-4975(02)04365-5
  5. Tanaka I, Inoue M, Matsui Y, et al. A case of pneumocytoma (so called sclerosing hemangioma) with lymph node metastasis. Jpn J Oncol 1986;16:77-86.
  6. Yano M, Tamakawa Y, Kiriyama M, Hara M, Murase T. Sclerosing hemangioma with metastases to multiple nodal stations. Ann Thorac Surg 2002;73:981-3. https://doi.org/10.1016/S0003-4975(01)03122-8
  7. Miyagawa-Hayashino A, Tazelaar HD, Langel DJ, Colby TV. Pulmonary sclerosing hemangioma with lymph node metastases:report of 4 cases. Arch Pathol Lab Med 2003;127:321-5.
  8. Katakura H, Sato M, Tanaka F, et al. Pulmonary sclerosing hemangioma with metastasis to the Mediastinal lymph node. Ann Thorac Surg 2005;80:2351-3. https://doi.org/10.1016/j.athoracsur.2004.06.099
  9. Komatsu T, Fukuse T, Wada H, Sakurai T. Pulmonary sclerosing hemangioma with pulmonary metastasis. Thorac Cardiovc Surg 2006;54:348-55. https://doi.org/10.1055/s-2005-872976
  10. Jungraithmayr W, Eggeling S, Kudwig C, Kayser G, Passlick B. Sclerosing hemangioma of the lung: a benign tumour with potential for malignancy? Ann Thorac Cardiovasc Surg 2006;12:352-4.
  11. Wei S, Tian K, Song X, Chen Y. Recurrence of pulmonary sclerosing hemangioma. Thorac Cardiovasc Surg 2008;56:117-22. https://doi.org/10.1055/s-2007-965575
  12. Ng WK, Fu KH, Wang E, Tang V. Sclerosing hemangioma of lung: a close cytologic mimicker of pulmonary adenocarcinoma. Diagn Cytopathol 2001;25:316-20. https://doi.org/10.1002/dc.2162
  13. Situ DR, Long H, Ma GW, Lin ZC, Yun JP, Rong TH. Diagnosis and therapeutics of 24 cases of pulmonary sclerosing hemangioma. Ai Zheng 2008;27:861-5.
  14. Kim GY, Kim J, Choi YS, Kim HJ, Ahn G, Han J. Sixteen cases of sclerosing hemangioma of the lung including unusual presentations. J Korean Med Sci 2004;19:352-8. https://doi.org/10.3346/jkms.2004.19.3.352

Cited by

  1. Pulmonary Sclerosing Pneumocytoma of the Lung: CT Characteristics in a Large Series of a Tertiary Referral Center vol.94, pp.4, 2011, https://doi.org/10.1097/md.0000000000000498
  2. Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis vol.25, pp.7, 2011, https://doi.org/10.1177/0218492317727668
  3. Sclerosing pneumocytoma diagnosed by preoperative endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) vol.4, pp.None, 2018, https://doi.org/10.1186/s40792-018-0429-0
  4. A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy vol.34, pp.None, 2011, https://doi.org/10.1016/j.rmcr.2021.101494